A Study on Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL)

NCT01178086 · clinicaltrials.gov ↗

COMPLETED

Status

681

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphocytic Leukemia, Chronic

Interventions

DRUG: Rituximab

Sponsor

Hoffmann-La Roche